Text Size

Effects of Lumbopelvic Manipulation on Hip and Knee Neuromuscular Activity

This study is currently recruiting participants.
Verified February 2013 by Texas Woman's University
Sponsor:
Information provided by (Responsible Party):
Texas Woman's University
ClinicalTrials.gov Identifier:
NCT01637480
First received: June 25, 2012
Last updated: February 26, 2013
Last verified: February 2013
History of Changes
  Purpose

The purpose of this study is to determined if a lower back treatment would change the hip and knee muscle activities in people with and without anterior knee pain. The investigators hypothesized that the lower back treatment may change the hip and knee muscle activities in people with anterior knee pain but not in people without anterior knee pain.


Condition Intervention
Patellofemoral Pain Syndrome
 Other: Lumbopelvic manipulation

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Effects of Lumbopelvic Manipulation on Hip and Knee Neuromuscular Activity in People With and Without Patellofemoral Pain Syndrome

Further study details as provided by Texas Woman's University:

Primary Outcome Measures:
  • Electromyography (EMG) [ Time Frame: The EMG data will be collected within 48 hours for all participants in both groups. On Day 1, data will be collected twice at baseline. On Day 2, data will be collected before and immediately after as well as 15, 30, and 45 min after the intervention. ] [ Designated as safety issue: No ]
    Electromyography (EMG) onset time of the gluteus maximus, gluteus medius, vastus medialis oblique, and vastus lateralis muscles.


Secondary Outcome Measures:
  • Pain Visual Analog Scale (VAS) [ Time Frame: The Pain Visual Analog Scale (VAS) will be assessed before and 45 min after the lower back treatment (lumbopelvic manipulation) for participants in the patellofemoral pain syndrome group on Day 2 only. ] [ Designated as safety issue: No ]
    Pain Visual Analog Scale (VAS) is a 100 mm continuous line between two end-points. The left end-point represents "no pain" and the right end-point represents the "worst pain imaginable".


Estimated Enrollment: 30
Study Start Date: July 2012
Estimated Study Completion Date: May 2013
Estimated Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Patellofemoral Pain Syndrome
Participants with Patellofemoral Pain Syndrome
 Other: Lumbopelvic manipulation
High-velocity-low-amplitude thrust manipulation of the lumbopelvic region
Active Comparator: Healthy control
Age- and gender-matched participants without Patellofemoral Pain Syndrome
 Other: Lumbopelvic manipulation
High-velocity-low-amplitude thrust manipulation of the lumbopelvic region

  Eligibility

Ages Eligible for Study:   18 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria for participants in the patellofemoral pain syndrome group:

  1. insidious onset of symptoms of non-traumatic origin
  2. pain with patellar facet palpation or compression

  3. subjective knee pain rating of at least 3/10 on the pain visual analog scale during at least one of the following activities:

    • ascending stair
    • descending stair
    • kneeling
    • squatting
    • running
    • jumping
    • prolong sitting for more than 20 minutes

Exclusion criteria for all participants:

  1. history of spine, hip or knee surgery
  2. history of hip pathology or other knee condition
  3. current significant injury of any lower extremity joints
  4. pregnancy
  5. sign of nerve root compression
  6. osteoporosis or history of compression fracture

Age- and gender- matched control participants will be recruited if they have no signs or symptoms of patellofemoral pain syndrome and have none of the exclusion criteria

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01637480

Locations
United States, Texas
Texas Woman's University, School of Physical Therapy - Dallas Campus Recruiting
Dallas, Texas, United States, 75235
Contact: Ammar M Al Abbad, Master     214-689-6745 ext 2     aalabbad@twu.edu    
Sponsors and Collaborators
Texas Woman's University
Investigators
Principal Investigator: Ammar M Al Abbad, Master Texas Woman's University
  More Information

No publications provided

Responsible Party: Texas Woman's University
ClinicalTrials.gov Identifier: NCT01637480     History of Changes
Other Study ID Numbers: 16882
Study First Received: June 25, 2012
Last Updated: February 26, 2013
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Somatoform Disorders
Patellofemoral Pain Syndrome
Mental Disorders
Joint Diseases
Musculoskeletal Diseases

ClinicalTrials.gov processed this record on May 22, 2013